Page last updated: 2024-08-23

mefloquine and Infections, Coronavirus

mefloquine has been researched along with Infections, Coronavirus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Andreani, J; Boxberger, M; Delandre, O; Duflot, I; Fonta, I; Gendrot, M; Hutter, S; Jardot, P; La Scola, B; Le Bideau, M; Mosnier, J; Pradines, B; Rolland, C	1

Other Studies

1 other study(ies) available for mefloquine and Infections, Coronavirus

Article	Year
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Virus Replication	2020

Article

Year

Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99

Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Virus Replication

2020